Mammalian Cell Fermentation Technology Market Players:
- Shanghai Henlius Biotech, Inc.
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Evonik
- Thermo Fisher Scientific Inc.
- General Electric
- Danaher Corporation
- Merck KGaA
- Sartorius AG
- Amgen, Inc.
- Eppendorf AG
- Pall Corporation
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
In the year 2026, the industry size of mammalian cell fermentation technology is estimated at USD 51.77 billion.
The global mammalian cell fermentation technology market size crossed USD 48.09 billion in 2025 and is likely to register a CAGR of over 8.5%, exceeding USD 108.73 billion revenue by 2035.
The North America mammalian cell fermentation technology market is anticipated to command around 35% share by 2035, fueled by rising investment in biotechnology.
Key players in the market include Illumina, Inc., Thermo Fisher Scientific Inc., Roche Holding AG, Qiagen N.V., Foundation Medicine, Inc., Guardant Health, Inc., Myriad Genetics, Inc., Agilent Technologies, Inc., Personalis, Inc., NeoGenomics Laboratories, Inc.
